- Home
- ELVA vs ASRT Comparison
ELVA vs ASRT Comparison
Compare ELVA & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- ASRT
- Stock Information
- Founded
- ELVA 1996
- ASRT 1995
- Country
- ELVA Canada
- ASRT United States
- Employees
- ELVA N/A
- ASRT N/A
- Industry
- ELVA
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- ELVA
- ASRT Health Care
- Exchange
- ELVA Nasdaq
- ASRT Nasdaq
- Market Cap
- ELVA 91.8M
- ASRT 78.3M
- IPO Year
- ELVA N/A
- ASRT 1997
- Fundamental
- Price
- ELVA $2.53
- ASRT $0.67
- Analyst Decision
- ELVA Strong Buy
- ASRT Strong Buy
- Analyst Count
- ELVA 5
- ASRT 3
- Target Price
- ELVA $6.10
- ASRT $3.08
- AVG Volume (30 Days)
- ELVA 67.3K
- ASRT 412.7K
- Earning Date
- ELVA 05-12-2025
- ASRT 05-05-2025
- Dividend Yield
- ELVA N/A
- ASRT N/A
- EPS Growth
- ELVA N/A
- ASRT N/A
- EPS
- ELVA N/A
- ASRT N/A
- Revenue
- ELVA $43,693,000.00
- ASRT $124,961,000.00
- Revenue This Year
- ELVA $55.23
- ASRT N/A
- Revenue Next Year
- ELVA $63.75
- ASRT $11.20
- P/E Ratio
- ELVA N/A
- ASRT N/A
- Revenue Growth
- ELVA N/A
- ASRT N/A
- 52 Week Low
- ELVA $1.67
- ASRT $0.65
- 52 Week High
- ELVA $3.58
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- ELVA 51.80
- ASRT 35.44
- Support Level
- ELVA $2.30
- ASRT $0.70
- Resistance Level
- ELVA $2.70
- ASRT $0.80
- Average True Range (ATR)
- ELVA 0.17
- ASRT 0.05
- MACD
- ELVA -0.01
- ASRT -0.00
- Stochastic Oscillator
- ELVA 37.10
- ASRT 15.22
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.